| abstract |
The present invention comprises mammalian amino acid racemic enzymes and compositions comprising the enzymes. Polynucleotides encoding the enzymes of the invention, expression vectors containing apolinucleotides, host cells carrying the expression vectors, and many of the enzymes of the invention are more likely to form the present invention. The present invention also provides methods for isolating active ingredients capable of modulating the activity of the enzymes of the present invention. According to the present invention, the solution is suitable for the identification of new active ingredients which can be used for the treatment of diseases of the nervous system. SHE |